RSS Feeds
Retrobulbar Optic Neuritis Associated with Infliximab in a Patient with Crohn Disease
- Betsy Y.C. Strong, MD;
- Barbara C. Erny, MD;
- Howard Herzenberg, MD; and
- Kristen J. Razzeca, MD
- From Camino Medical Group, Sunnyvale, CA 94086.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Case Report: A 45-year-old woman with type 2 diabetes mellitus and Crohn disease developed retrobulbar optic neuritis that was temporally associated with infliximab treatment. Three years earlier, she had Bell palsy, which resolved. Two years earlier, she received a diagnosis of Crohn disease and …
